ESR1 and breast carcinoma: MiR-101 was found to attenuate SNHG6-mediated effects on tamoxifen resistance, EMT, and stem cell markers, presenting a crucial role for the SNHG6-miR-101 axis in tamoxifen resistance of ER-positive breast cancer cells.